A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection (Q42203598)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 July 2014
edit
Language Label Description Also known as
English
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
scientific article published on 24 July 2014

    Statements

    A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection (English)
    Andrew J Muir
    Sanjeev Arora
    Gregory Everson
    Jacob George
    Reem Ghalib
    Stuart C Gordon
    Todd Gray
    Susan Greenbloom
    Tarek Hassanein
    Jan Hillson
    Maria Arantxa Horga
    Ira M Jacobson
    Lennox Jeffers
    Eric Lawitz
    Stefan Lueth
    Maribel Rodriguez-Torres
    Vinod Rustgi
    Lynn Shemanski
    Mitchell L Shiffman
    Subasree Srinivasan
    John M Vierling
    Juan C Lopez-Talavera
    EMERGE study group
    24 July 2014
    1238-1246

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit